Literature DB >> 21443451

A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults.

Lance T Vernon1, Denise C Babineau, Catherine A Demko, Michael M Lederman, Xuelei Wang, Zahra Toossi, Aaron Weinberg, Benigno Rodriguez.   

Abstract

The determinants of HIV-associated cardiovascular disease (CVD) are not well understood. Periodontal disease (PD) has been linked to CVD but this connection has not been examined in HIV infection. We followed a cohort of HIV-infected adults to ascertain whether PD was associated with carotid artery intima media thickness (IMT) and brachial artery flow-mediated dilation (FMD). We performed a longitudinal observational study of HIV-infected adults on HAART for <2 years with no known heart disease. PD was characterized clinically and microbiologically. Cardiovascular disease was assessed by IMT/FMD. Linear mixed models assessed cross-sectional and longitudinal associations between PD and FMD/IMT. Forty three HIV(+) adults completed a median of 24 (6-44) months on the study. Defining delta to be the change in a variable between baseline and a follow-up time, longitudinally, on average and after adjusting for change in time, CVD-specific and HIV-specific potential confounding covariates, a 1-log(10) increase in delta Porphyromonas gingivalis was associated with a 0.013 mm increase in delta IMT (95% CI: 0.0006-0.0262; p=0.04). After adjusting for the same potential confounding covariates, a 10% increase in delta gingival recession was associated with a 2.3% increase in delta FMD (95% CI: 0.4-4.2; p=0.03). In a cohort of HIV-infected adults, an increase in subgingival Porphyromonas gingivalis, a known periodontal pathogen, was significantly associated with longitudinal increases in IMT, while increased gingival recession, which herein may represent PD resolution, was significantly associated with longitudinal improvement in FMD. In the context of HIV infection, PD may contribute to CVD risk. Intervention studies treating PD may help clarify this association.

Entities:  

Mesh:

Year:  2011        PMID: 21443451      PMCID: PMC3206743          DOI: 10.1089/AID.2010.0320

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  59 in total

1.  Bleeding on probing differentially relates to bacterial profiles: the Oral Infections and Vascular Disease Epidemiology Study.

Authors:  Ryan T Demmer; Panos N Papapanou; David R Jacobs; Moïse Desvarieux
Journal:  J Clin Periodontol       Date:  2008-04-09       Impact factor: 8.728

Review 2.  Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis.

Authors:  Linda L Humphrey; Rongwei Fu; David I Buckley; Michele Freeman; Mark Helfand
Journal:  J Gen Intern Med       Date:  2008-09-20       Impact factor: 5.128

3.  Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells.

Authors:  Andreas Pollreisz; Barry I Hudson; Jong S Chang; Wu Qu; Bin Cheng; Panos N Papapanou; Ann Marie Schmidt; Evanthia Lalla
Journal:  Atherosclerosis       Date:  2010-07-21       Impact factor: 5.162

4.  Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.

Authors:  Takanari Miyamoto; Hiromichi Yumoto; Yusuke Takahashi; Michael Davey; Frank C Gibson; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 5.  Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways.

Authors:  C Hayashi; C V Gudino; F C Gibson; C A Genco
Journal:  Mol Oral Microbiol       Date:  2010-10       Impact factor: 3.563

6.  Associations between IgG antibody to oral organisms and carotid intima-medial thickness in community-dwelling adults.

Authors:  James D Beck; Paul Eke; Dongming Lin; Phoebus Madianos; David Couper; Kevin Moss; John Elter; Gerardo Heiss; Steven Offenbacher
Journal:  Atherosclerosis       Date:  2005-12       Impact factor: 5.162

7.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

8.  Estimation of HIV incidence in the United States.

Authors:  H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen
Journal:  JAMA       Date:  2008-08-06       Impact factor: 56.272

9.  Characterizing traditionally defined periodontal disease in HIV+ adults.

Authors:  Lance T Vernon; Catherine A Demko; Christopher C Whalen; Michael M Lederman; Zahra Toossi; Mianda Wu; Yiping W Han; Aaron Weinberg
Journal:  Community Dent Oral Epidemiol       Date:  2009-07-14       Impact factor: 3.383

10.  Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients.

Authors:  Jeroen P H van Wijk; Eelco J P de Koning; Manuel Castro Cabezas; Jorge Joven; Jos op't Roodt; Ton J Rabelink; Andy M Hoepelman
Journal:  J Am Coll Cardiol       Date:  2006-02-23       Impact factor: 24.094

View more
  11 in total

1.  Advancing Health Promotion in Dentistry: Articulating an Integrative Approach to Coaching Oral Health Behavior Change in the Dental Setting.

Authors:  Lance T Vernon; Anita R Howard
Journal:  Curr Oral Health Rep       Date:  2015-07-25

2.  Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.

Authors:  Rachel M Presti; Scott A Handley; Lindsay Droit; Mahmoud Ghannoum; Mark Jacobson; Caroline H Shiboski; Jennifer Webster-Cyriaque; Todd Brown; Michael T Yin; Edgar T Overton
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

3.  Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.

Authors:  L T Vernon; Plp Jayashantha; M M Chidzonga; M C Komesu; R G Nair; N W Johnson
Journal:  Oral Dis       Date:  2016-04       Impact factor: 3.511

Review 4.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

5.  Prevalence of periodontal diseases in a multicenter cohort of perinatally HIV-infected and HIV-exposed and uninfected youth.

Authors:  Mark I Ryder; Tzy-Jyun Yao; Jonathan S Russell; Anna-Barbara Moscicki; Caroline H Shiboski
Journal:  J Clin Periodontol       Date:  2016-11-22       Impact factor: 8.728

6.  Clinical Oral Condition Analysis and the Influence of Highly Active Antiretroviral Therapy on Human Salivary Microbial Community Diversity in HIV-Infected/AIDS Patients.

Authors:  Peilin Cao; Yifan Zhang; Guangyan Dong; Hongkun Wu; Yuxiang Yang; Yi Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-29       Impact factor: 6.073

7.  HIV-related stigma in the dental setting: a qualitative study.

Authors:  Natisha Patel; Jennifer J Furin; Danae J Willenberg; Nicole J Apollon Chirouze; Lance T Vernon
Journal:  Spec Care Dentist       Date:  2014-07-15

Review 8.  Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review.

Authors:  Minyahil Woldu; Omary Minzi; Ephrem Engidawork
Journal:  J Diabetes Metab Disord       Date:  2020-06-09

9.  Effect of Nadir CD4+ T cell count on clinical measures of periodontal disease in HIV+ adults before and during immune reconstitution on HAART.

Authors:  Lance T Vernon; Catherine A Demko; Denise C Babineau; Xuelei Wang; Zahra Toossi; Aaron Weinberg; Benigno Rodriguez
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

10.  Evaluation of right ventricular function by Doppler tissue imaging of the tricuspid annulus in patients with acquired immune deficiency syndrome.

Authors:  Haohui Zhu; Jianjun Yuan; Changhua Wei; Jiyun Chen; Yisa Wang
Journal:  Exp Ther Med       Date:  2014-01-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.